)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Phreesia
Phreesia (PHR) investor relations material
Phreesia Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary2 Sep, 2026
Executive summary
Achieved 10% year-over-year revenue growth to $129.5M in Q2 FY2027, with net income rising to $1.9M and Adjusted EBITDA up 49% year-over-year to $32.9M; free cash flow increased to $13.8M.
Reduced debt principal by over $23M, ending the quarter with $74.6M in cash, cash equivalents, and restricted cash.
Product innovation and expansion, including AccessOne and ProviderConnect, are driving value and extending market reach, with early wins and positive client feedback.
A restructuring plan was implemented in May 2026, eliminating approximately 220 positions and incurring $2.8M in charges this quarter, with expected total charges of $10M.
Investments in AI and new products are expected to drive future growth and operational efficiency.
Financial highlights
Q2 FY2027 revenue was $129.5M, up 10% year-over-year and down 1% sequentially; net income was $1.9M, up 193% year-over-year.
Adjusted EBITDA reached $32.9M, up $10.8M year-over-year, with a margin of approximately 25%.
Free cash flow was $13.8M for the quarter; cash, cash equivalents, and restricted cash stood at $74.6M as of July 31, 2026.
Payment solutions revenue surged 36% year-over-year, driven by the AccessOne acquisition and new client additions.
Total managed payments reached $1.626B for the quarter, with a payment solutions revenue rate of 2.4%.
Outlook and guidance
Fiscal 2027 revenue outlook maintained at $510M–$520M, including $37M from AccessOne; Adjusted EBITDA guidance remains $125M–$135M.
Expecting mid-single-digit percentage growth in AHSCs and low-single-digit growth in revenue per AHSC for FY2027.
Management expects meaningful run-rate cost savings from the restructuring plan implemented in May 2026.
Sufficient liquidity to meet obligations and achieve outlook for at least the next twelve months.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Phreesia
- All proposals, including director elections and auditor ratification, were approved by stockholders.PHR
AGM 2026 - Q1 FY2027 revenue up 13%, net income $3M, and FY2027 guidance reaffirmed.PHRQ1 2027
- Proxy seeks approval for director elections, auditor ratification, and executive pay, highlighting governance and ESG.PHRProxy filing
- Key votes include director elections, auditor ratification, and executive pay approval.PHRProxy filing
- FY27 revenue guidance lowered on pharma headwinds, but margin and cash flow outlooks remain strong.PHRQ4 2026
- Q3 FY2026 saw 13% revenue growth, profitability, and a major acquisition completed.PHRQ3 2026
- Revenue up 17%, net loss narrowed, and Adjusted EBITDA positive with strong outlooks ahead.PHRQ3 2025
- Revenue up 19%, net loss halved, and positive free cash flow achieved in Q2 FY25.PHRQ2 2025
- Double-digit revenue growth, positive cash flow, and strong 2026 outlook maintained.PHRQ4 2025
Next Phreesia earnings date
Q3 20272 Dec, 2026
Phreesia
Next Phreesia earnings date
Q3 20272 Dec, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its platform offers patient registration and intake management solutions, including online pre-registration and scheduling, pre-visit questionnaires capture, clinical decision support, co-pay collection, and medical device integration; SaaS applications for practice management and electronic health records systems; Phreesia Central that offers a Web-based application to manage all of its site locations; and Phreesia Mobile through a mobile device. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.